Regent Pacific Group Ltd. Stock Hong Kong S.E.
Equities
0575
KYG7478U1388
Pharmaceuticals
Sales 2022 | 35K 273K 47.87K | Sales 2023 | 291K 2.27M 398K | Capitalization | 18.13M 142M 24.8M |
---|---|---|---|---|---|
Net income 2022 | -36M -281M -49.24M | Net income 2023 | -25M -195M -34.19M | EV / Sales 2022 | 1,045 x |
Net Debt 2022 | 12.29M 95.98M 16.81M | Net cash position 2023 | 1.22M 9.53M 1.67M | EV / Sales 2023 | 58.1 x |
P/E ratio 2022 |
-0.67
x | P/E ratio 2023 |
-0.71
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.23% |
Managers | Title | Age | Since |
---|---|---|---|
Jamie Gibson
CEO | Chief Executive Officer | 58 | 96-03-31 |
Jim Mellon
FOU | Founder | 68 | 89-12-31 |
Yui Fui Wong
DFI | Director of Finance/CFO | 49 | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jim Mellon
FOU | Founder | 68 | 89-12-31 |
Jamie Gibson
CEO | Chief Executive Officer | 58 | 96-03-31 |
Stawell Searle
BRD | Director/Board Member | 80 | 01-09-30 |
1st Jan change | Capi. | |
---|---|---|
+55.32% | 815B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |